Health product recall

Seasonique tablet; may be packaged with extra yellow tablets (ethinyl estradiol)

Last updated

Summary

Product
Seasonique tablet
Issue
Health products - Packaging
What to do

Do not skip doses or stop taking Seasonique. If your package contains an extra row of yellow pills in Tray 1 and/or 2 of the blister cards, do not take them. Instead, return the product to your pharmacy for a replacement or alternative product. If you cannot get to a pharmacy right away, take the next blue-green pill in the proper order as noted in the instructions until you are able to contact your pharmacist and obtain a replacement or alternative product.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot number
Teva Canada Seasonique tablet DIN 02346176 Tablet Ethinyl estradiol 0.01 mg Ethinyl estradiol 0.03 mg Levonorgestrel 0.15 mg 100069151

Issue

Affected lots may be packaged with sealed blisters containing extra yellow tablets (ethinyl estradiol).

What you should do

  • Do not stop taking Seasonique. Do not skip taking any blue–green
  • Check your package. If your package contains an extra row of yellow pills in Tray 1 and/or 2 of the blister cards, do not take them. Instead, return it to your pharmacy for a replacement or an alternative product.
  • If you cannot get to a pharmacy right away, take the next blue–green pill in the proper order as noted in the instructions until you are able to contact your pharmacist and obtain a replacement or alternative product.
  • If you are unsure whether your package contains the correct pills, talk to your pharmacist.
  • If you took a yellow pill instead of a blue-green pill from Tray 1 and/or 2, or if you are unsure, you should also use another method of non-hormonal back-up contraception (such as condoms) and consult with your health care professional. Talk to a health care professional if you have any other questions or concerns about your birth control product.
  • Contact Teva Canada Ltd. by calling toll-free at 1-800-268-4127, Option 3, or by email at druginfo@tevacanada.com if you have questions about this recall.
  • Report any health product-related adverse reactions or complaints to Health Canada

Additional information

Background

Depth of recall: End Users

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Teva Canada Limited
30 Novopharm Court
Toronto Ontario M1B 2K9 Canada 

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-77568
Media and public enquiries

Media Inquiries:

Health Canada

613-957-2983

media@hc-sc.gc.ca

Public Enquiries:

613-957-2991

1-866-225-0709

info@hc-sc.gc.ca

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe